BHVN
Biohaven Pharmaceutical Holding Company Ltd

3,368
Mkt Cap
$1.67B
Volume
2.92M
52W High
$36.95
52W Low
$7.48
PE Ratio
-1.52
BHVN Fundamentals
Price
$11.52
Prev Close
$11.15
Open
$11.00
50D MA
$11.59
Beta
1.60
Avg. Volume
3.14M
EPS (Annual)
-$9.28
P/B
-71.03
Rev/Employee
$0.00
$2,957.92
Loading...
Loading...
News
all
press releases
Biohaven Ltd. (NYSE:BHVN) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eighteen ratings firms that are covering the stock, MarketBeat reports...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Biohaven (BHVN) Projected to Post Earnings on Monday
Biohaven (NYSE:BHVN) will be releasing its Q4 2025 earnings before the market opens on Monday, March 2. (View Earnings Report at...
MarketBeat·6d ago
News Placeholder
Is Biohaven Ltd. (BHVN) Stock Outpacing Its Medical Peers This Year?
Here is how Biohaven Ltd. (BHVN) and Caribou Biosciences, Inc. (CRBU) have performed compared to their sector so far this year.
Zacks·19d ago
News Placeholder
Biohaven (NYSE:BHVN) Stock Price Up 8.4% - Should You Buy?
Biohaven (NYSE:BHVN) Stock Price Up 8.4% - Still a Buy...
MarketBeat·20d ago
News Placeholder
Does Biohaven Ltd. (BHVN) Have the Potential to Rally 82.16% as Wall Street Analysts Expect?
The consensus price target hints at an 82.2% upside potential for Biohaven Ltd. (BHVN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks·20d ago
News Placeholder
Biohaven Ltd. (NYSE:BHVN) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Biohaven Ltd. (NYSE:BHVN - Get Free Report) have been given an average rating of "Moderate Buy" by the seventeen research firms that are covering the firm, Marketbeat.com reports. One...
MarketBeat·29d ago
News Placeholder
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year?
Here is how Amneal Pharmaceuticals (AMRX) and Biohaven Ltd. (BHVN) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
Biohaven (NYSE:BHVN) Shares Gap Up - What's Next?
Biohaven (NYSE:BHVN) Shares Gap Up - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Biohaven (NYSE:BHVN) Stock Price Up 8% - Still a Buy?
Biohaven (NYSE:BHVN) Trading 8% Higher - Here's Why...
MarketBeat·1mo ago
News Placeholder
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference Biohaven Highlights...
PR Newswire·2mo ago
<
1
2
...
>

Latest BHVN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.